[go: up one dir, main page]

WO1999021538A3 - Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete - Google Patents

Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete Download PDF

Info

Publication number
WO1999021538A3
WO1999021538A3 PCT/EP1998/006703 EP9806703W WO9921538A3 WO 1999021538 A3 WO1999021538 A3 WO 1999021538A3 EP 9806703 W EP9806703 W EP 9806703W WO 9921538 A3 WO9921538 A3 WO 9921538A3
Authority
WO
WIPO (PCT)
Prior art keywords
eye
pharmaceutical preparations
glycosaminoglycans
treating diabetes
associated diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/006703
Other languages
German (de)
English (en)
Other versions
WO1999021538A2 (fr
Inventor
DER WOUDE Fokko VAN
Dieter Herr
Volker Laux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU13355/99A priority Critical patent/AU749673B2/en
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to KR1020007004363A priority patent/KR20010024550A/ko
Priority to JP2000517697A priority patent/JP2001520987A/ja
Priority to CA002306379A priority patent/CA2306379A1/fr
Priority to EP98956862A priority patent/EP1047434A2/fr
Priority to HU0004647A priority patent/HUP0004647A3/hu
Priority to BR9813098-6A priority patent/BR9813098A/pt
Priority to IL13517198A priority patent/IL135171A0/xx
Publication of WO1999021538A2 publication Critical patent/WO1999021538A2/fr
Publication of WO1999021538A3 publication Critical patent/WO1999021538A3/fr
Priority to NO20001895A priority patent/NO20001895L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne l'utilisation de glycosaminoglycanes pour la fabrication de préparations pharmaceutiques destinées à la prévention ou au traitement de maladies des yeux associées au diabète. L'invention concerne d'autre part des préparations pharmaceutiques appropriées pour le traitement de maladies des yeux associées au diabète.
PCT/EP1998/006703 1997-10-24 1998-10-22 Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete Ceased WO1999021538A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL13517198A IL135171A0 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
KR1020007004363A KR20010024550A (ko) 1997-10-24 1998-10-22 당뇨병에 관련된 안질환 치료용 제약 제제 제조에있어서의 글리코사미노글리칸의 용도
JP2000517697A JP2001520987A (ja) 1997-10-24 1998-10-22 糖尿病に関連する眼疾患治療用の医薬品製剤を製造するためのグリコサミノグリカンの使用
CA002306379A CA2306379A1 (fr) 1997-10-24 1998-10-22 Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete
EP98956862A EP1047434A2 (fr) 1997-10-24 1998-10-22 Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete
AU13355/99A AU749673B2 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
BR9813098-6A BR9813098A (pt) 1997-10-24 1998-10-22 Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
HU0004647A HUP0004647A3 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
NO20001895A NO20001895L (no) 1997-10-24 2000-04-12 Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195.1 1997-10-24
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten

Publications (2)

Publication Number Publication Date
WO1999021538A2 WO1999021538A2 (fr) 1999-05-06
WO1999021538A3 true WO1999021538A3 (fr) 1999-08-05

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/006703 Ceased WO1999021538A2 (fr) 1997-10-24 1998-10-22 Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete

Country Status (13)

Country Link
EP (1) EP1047434A2 (fr)
JP (1) JP2001520987A (fr)
KR (1) KR20010024550A (fr)
CN (1) CN1277554A (fr)
AU (1) AU749673B2 (fr)
BR (1) BR9813098A (fr)
CA (1) CA2306379A1 (fr)
DE (1) DE19747195A1 (fr)
HU (1) HUP0004647A3 (fr)
IL (1) IL135171A0 (fr)
NO (1) NO20001895L (fr)
WO (1) WO1999021538A2 (fr)
ZA (1) ZA989665B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
JPWO2011122321A1 (ja) * 2010-03-29 2013-07-08 国立大学法人名古屋大学 ヘパリン結合性蛋白に対する生理活性阻害剤
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244298A2 (fr) * 1986-04-17 1987-11-04 Sanofi Oligosaccharides hépariniques affinés pour les facteurs de croissance cellulaires
WO1990000058A1 (fr) * 1988-06-27 1990-01-11 Roland Reiner Glycosaminoglycane pour le traitement de la microangiopathie des diabetiques
EP0394971A1 (fr) * 1989-04-24 1990-10-31 Kabi Pharmacia Ab Inhibiteurs de croissance de cellules endothéoliales et d'angiogénèse contenant un oligosaccharide
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
WO1995005182A1 (fr) * 1993-08-13 1995-02-23 Glycomed Incorporated Oligosaccharides pontes et leurs derives sulfates
WO1995009637A1 (fr) * 1993-10-07 1995-04-13 Glycomed Incorporated Maltooligosaccharides fortement sulfatees presentant des proprietes semblables a l'heparine
WO1996040158A1 (fr) * 1995-06-07 1996-12-19 Baker Norton Pharmaceuticals, Inc. Methode de traitement des maladies vasculaires evolutives chroniques
WO1999004801A1 (fr) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Utilisation de glycosaminoglycanes sulfates dans le traitement de la retinopathie

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244298A2 (fr) * 1986-04-17 1987-11-04 Sanofi Oligosaccharides hépariniques affinés pour les facteurs de croissance cellulaires
WO1990000058A1 (fr) * 1988-06-27 1990-01-11 Roland Reiner Glycosaminoglycane pour le traitement de la microangiopathie des diabetiques
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
EP0394971A1 (fr) * 1989-04-24 1990-10-31 Kabi Pharmacia Ab Inhibiteurs de croissance de cellules endothéoliales et d'angiogénèse contenant un oligosaccharide
WO1995005182A1 (fr) * 1993-08-13 1995-02-23 Glycomed Incorporated Oligosaccharides pontes et leurs derives sulfates
WO1995009637A1 (fr) * 1993-10-07 1995-04-13 Glycomed Incorporated Maltooligosaccharides fortement sulfatees presentant des proprietes semblables a l'heparine
WO1996040158A1 (fr) * 1995-06-07 1996-12-19 Baker Norton Pharmaceuticals, Inc. Methode de traitement des maladies vasculaires evolutives chroniques
WO1999004801A1 (fr) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Utilisation de glycosaminoglycanes sulfates dans le traitement de la retinopathie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
P. DI GIACOMO ET AL: "Efficacia terapeutica dell'eparansolfato nella retinopatia diabetica incipente", QUAD.MED.CHIR, vol. 11, no. 3, 1995, pages 370 - 373, XP002096378 *

Also Published As

Publication number Publication date
HUP0004647A2 (hu) 2001-05-28
NO20001895D0 (no) 2000-04-12
IL135171A0 (en) 2001-05-20
JP2001520987A (ja) 2001-11-06
ZA989665B (en) 2000-04-25
DE19747195A1 (de) 1999-04-29
CN1277554A (zh) 2000-12-20
NO20001895L (no) 2000-04-12
WO1999021538A2 (fr) 1999-05-06
AU1335599A (en) 1999-05-17
EP1047434A2 (fr) 2000-11-02
HUP0004647A3 (en) 2002-01-28
AU749673B2 (en) 2002-07-04
BR9813098A (pt) 2000-08-15
CA2306379A1 (fr) 1999-05-06
KR20010024550A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
AU5869796A (en) Micromechanical patch for enhancing the delivery of compound s through the skin
CA2272584A1 (fr) Nouveaux derives de pyrazole substitues pour le traitement de maladies cardio-vasculaires
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU7060896A (en) Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
AU2752892A (en) Fusion proteins targeted to lysosomes, for the treatment of aids
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
WO2000040273A3 (fr) Traitement de maladies virales a l'aide d'un polynucleotide exprimant l'interferon omega
AU8893098A (en) Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU5539798A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
WO1999021538A3 (fr) Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
NO905364D0 (no) Fremgangsmaate ved fremstilling av alkansyrederivater.
AU3360000A (en) Use of 4-amino pyridine for treatment of peripheral neuropathies
AU5699396A (en) Compositions for the treatment of skin conditions
EP0302303A3 (fr) Composés bicycliques, leur utilisation pharmaceutique, leur préparation et intermédiaires pour leur préparation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 135171

Country of ref document: IL

Ref document number: 98810527.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1998956862

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2306379

Country of ref document: CA

Ref document number: 2306379

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/003598

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 09529827

Country of ref document: US

Ref document number: 13355/99

Country of ref document: AU

Ref document number: PV2000-1455

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 1020007004363

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: PV2000-1455

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1998956862

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020007004363

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 13355/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1020007004363

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1998956862

Country of ref document: EP